The BOJ's Ongoing ETF Impact - Is a Nikkei 225 Reshuffle in the Cards?
Just over six months ago, a breathless article on Bloomberg noted that according to their calculations, the BOJ owned 71% of the ETFs in the...
1.6k Views
Last Week in Event SPACE - Astellas, Celltrion, Renesas, AWE, Viva, Kushikatsu
Last week, Astellas Pharma Inc (4503 JP)'s latest buyback may impact the stock; KOSDAQ 150 names expected to benefit as Celltrion Inc (068270 KS)...
221 Views
Astellas (4503 JP) Buyback - How It Stacks Up Against Past Buybacks
A small note about the buyback. There is more here than meets the eye.Today, Astellas Pharma Inc (4503 JP)announced a buyback program to repurchase...
212 Views
Industrial Capsule: Pharmaceuticals in Japan
Industry’s growth facilitated by healthcare spending as Japan’s society agesThe revenue of Japanese pharmaceutical producers continued to grow in...
130 Views
Global Pharmaceuticals: Valuations, Assets and Leverage Up - Margins Down
We examined ten years of accounting and valuation data for the pharmaceutical companies around the world with sales of US$100m+ and created...
503 Views